BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33207287)

  • 1. Application of liver acquisition with volume acceleration enhanced sequence in improving the accuracy of reassessing organ-invasive rectal mucinous adenocarcinoma after chemoradiation.
    Cao W; Zou Q; Zhao Y; Zhou J; Li W; Ren D; Meng X; Hu B; Zhou Z
    Eur J Radiol; 2020 Dec; 133():109368. PubMed ID: 33207287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted magnetic resonance imaging of mucin pools in locally advanced rectal mucinous adenocarcinoma predicts tumor response to neoadjuvant therapy.
    Cao W; Li B; Gong J; Hu M; Li W; Pan X; Zhou Z
    Eur J Radiol; 2020 Apr; 125():108890. PubMed ID: 32092684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative MRI assessment of mucinous rectal adenocarcinoma to predict tumour response after neoadjuvant therapy.
    Cao W; Li Z; Mohamoud A; Gong J; Wang X; Zhou J; Hu H; Huang Y; Li W; Li F; Liu D; Liang C; Zhou Z
    Clin Radiol; 2019 Apr; 74(4):278-286. PubMed ID: 30686505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver acquisition with acceleration volume acquisition gadolinium-enhanced magnetic resonance combined with T2 sequences in the diagnosis of local recurrence of rectal cancer.
    Cao W; Li F; Gong J; Liu D; Deng Y; Kang L; Zhou Z
    J Xray Sci Technol; 2016 Nov; 24(6):855-863. PubMed ID: 27612049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucinous Degeneration on MRI After Neoadjuvant Therapy in Patients With Rectal Adenocarcinoma: Frequency and Association With Clinical Outcomes.
    Miranda J; Pinto PVA; Kinochita F; Garcia CM; El Homsi M; Vilela de Oliveira C; Pandini RV; Nahas CSR; Nahas SC; Gollub MJ; Horvat N
    AJR Am J Roentgenol; 2023 Aug; 221(2):206-216. PubMed ID: 36919880
    [No Abstract]   [Full Text] [Related]  

  • 6. The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease.
    Barbaro B; Leccisotti L; Vecchio FM; Di Matteo M; Serra T; Salsano M; Poscia A; Coco C; Persiani R; Alfieri S; Gambacorta MA; Valentini V; Giordano A; Bonomo L
    Br J Radiol; 2017 Jan; 90(1069):20150836. PubMed ID: 27845566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.
    Ippolito D; Drago SG; Pecorelli A; Maino C; Querques G; Mariani I; Franzesi CT; Sironi S
    World J Gastroenterol; 2020 May; 26(20):2657-2668. PubMed ID: 32523318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy.
    Park MJ; Kim SH; Lee SJ; Jang KM; Rhim H
    Radiology; 2011 Sep; 260(3):771-80. PubMed ID: 21846762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy.
    Kim SH; Lee JM; Hong SH; Kim GH; Lee JY; Han JK; Choi BI
    Radiology; 2009 Oct; 253(1):116-25. PubMed ID: 19789256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
    Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation.
    Oberholzer K; Menig M; Kreft A; Schneider A; Junginger T; Heintz A; Kreitner KF; Hötker AM; Hansen T; Düber C; Schmidberger H
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):842-8. PubMed ID: 21236593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer.
    Kim S; Han K; Seo N; Kim HJ; Kim MJ; Koom WS; Ahn JB; Lim JS
    Eur Radiol; 2018 Dec; 28(12):5231-5240. PubMed ID: 29858637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The value of MRI with CUBE sequence in early evaluation of the efficacy of neoadjuvant therapy for locally advanced rectal cancer].
    Wang X; Cao W; Liu D; Li F; Li W; Kang L; Deng Y; Zhou Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):73-78. PubMed ID: 29354903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer.
    Lambregts DM; Beets GL; Maas M; Kessels AG; Bakers FC; Cappendijk VC; Engelen SM; Lahaye MJ; de Bruïne AP; Lammering G; Leiner T; Verwoerd JL; Wildberger JE; Beets-Tan RG
    Ann Surg; 2011 Mar; 253(3):539-45. PubMed ID: 21239980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucinous rectal cancer: concepts and imaging challenges.
    Horvat N; Hope TA; Pickhardt PJ; Petkovska I
    Abdom Radiol (NY); 2019 Nov; 44(11):3569-3580. PubMed ID: 30993392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study.
    Shaish H; Aukerman A; Vanguri R; Spinelli A; Armenta P; Jambawalikar S; Makkar J; Bentley-Hibbert S; Del Portillo A; Kiran R; Monti L; Bonifacio C; Kirienko M; Gardner KL; Schwartz L; Keller D
    Eur Radiol; 2020 Nov; 30(11):6263-6273. PubMed ID: 32500192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes?
    Lahaye MJ; Beets GL; Engelen SM; Kessels AG; de Bruïne AP; Kwee HW; van Engelshoven JM; van de Velde CJ; Beets-Tan RG
    Radiology; 2009 Jul; 252(1):81-91. PubMed ID: 19403848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal cancer: MR imaging in local staging--is gadolinium-based contrast material helpful?
    Vliegen RF; Beets GL; von Meyenfeldt MF; Kessels AG; Lemaire EE; van Engelshoven JM; Beets-Tan RG
    Radiology; 2005 Jan; 234(1):179-88. PubMed ID: 15550372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
    J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rectal cancer: assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI.
    Oberholzer K; Menig M; Pohlmann A; Junginger T; Heintz A; Kreft A; Hansen T; Schneider A; Lollert A; Schmidberger H; Christoph D
    J Magn Reson Imaging; 2013 Jul; 38(1):119-26. PubMed ID: 23188618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.